Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELOâ„¢ ...
The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.
Pharmaceutical Technology on MSN
MEDIPOST, Teikoku Seiyaku partner for CARTISTEM commercialisation in Japan
MEDIPOST has announced a multi-year exclusive partnership with Teikoku Seiyaku to commercialise CARTISTEM, an allogeneic stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback